Current NDC auxiliary source row compounder:580

This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.

Complete normalized row#

Record Source: ndc_compounder_zip
Product Ndc Raw: 72682-6858
Product Ndc: 72682-6858
Product Ndc Digits: 726826858
Product Type Name: HUMAN COMPOUNDED DRUG
Proprietary Name: PlenishIV Nutrient Cocktail 50mL
Proprietary Name Suffix: [empty]
Nonproprietary Name: Dexpanthenol 6.6 mg/mL / Pyridoxine HCl 2.7 mg/mL / Thiamine HCl 2.6 mg/mL / Niacinamide 2.6 mg/mL / Riboflavin 0.05 mg/mL/ Magnesium Chloride Hexahydrate 10.5 mg/mL / Calcium Gluconate1.3 mg/mL / Cyanocobalamin 0.03 mg/mL 50mL
Dosage Form Name: INJECTION
Route Name: INTRAMUSCULAR; INTRAVENOUS
Marketing Category Name: OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Name: AnazaoHealth Corporation
Establishment Name: AnazaoHealth Corporation
Establishment Fei: [empty]
Substance Name: PYRIDOXINE HYDROCHLORIDE; MAGNESIUM CHLORIDE; DEXPANTHENOL; CALCIUM GLUCONATE; THIAMINE HYDROCHLORIDE; NIACINAMIDE; CYANOCOBALAMIN; RIBOFLAVIN
Active Ingredients Info: 2.7 mg/1 mL; 10.5 mg/1 mL; 6.6 mg/1 mL; 1.3 mg/1 mL; 75 mg/1 mL; 2.6 mg/1 mL; .03 mg/1 mL; .05 mg/1 mL
History Active Ingredients Raw: PYRIDOXINE HYDROCHLORIDE; MAGNESIUM CHLORIDE; DEXPANTHENOL; CALCIUM GLUCONATE; THIAMINE HYDROCHLORIDE; NIACINAMIDE; CYANOCOBALAMIN; RIBOFLAVIN
History Active Ingredients Info Raw: 2.7 mg/1 mL; 10.5 mg/1 mL; 6.6 mg/1 mL; 1.3 mg/1 mL; 75 mg/1 mL; 2.6 mg/1 mL; .03 mg/1 mL; .05 mg/1 mL
History Dosage Raw: INJECTION
Dea Schedule: [empty]
Package Ndc Raw: 72682-6858-1
Package Ndc: 72682-6858-1
Package Ndc Digits: 7268268581
Package Ndc11: 72682685801
Package Description: 50 mL in 1 VIAL (72682-6858-1)
Reporting Period Raw: 2025-1
Reporting Period: 2025-1
Normalization Status: valid
Source Url: https://www.accessdata.fda.gov/cder/compounders_ndc_directory.zip
Source Archive: compounders_ndc_directory.zip
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Last Modified: Fri, 18 Sep 2026 15:17:23 GMT
Source Archive Sha256: 222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
Source Member Sha256: f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
Source Record Id: compounder:580
Source Row Number: 580
Source Row Hash: 008361e3f34317c374d8cebfaa4b413ed17010d16730a2590d3f8282dfbdc45e
Import Run Id: 20261021T042902Z
Loaded At: 2026-10-21 04:33:26

Exact raw FDA source fields#

{
    "ROUTENAME": "INTRAMUSCULAR; INTRAVENOUS",
    "PRODUCTNDC": "72682-6858",
    "DEASCHEDULE": "",
    "LABELERNAME": "AnazaoHealth Corporation",
    "SUBSTANCENAME": "PYRIDOXINE HYDROCHLORIDE; MAGNESIUM CHLORIDE; DEXPANTHENOL; CALCIUM GLUCONATE; THIAMINE HYDROCHLORIDE; NIACINAMIDE; CYANOCOBALAMIN; RIBOFLAVIN",
    "DOSAGEFORMNAME": "INJECTION",
    "NDCPACKAGECODE": "72682-6858-1",
    "PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
    "PROPRIETARYNAME": "PlenishIV Nutrient Cocktail 50mL",
    "REPORTINGPERIOD": "2025-1",
    "NONPROPRIETARYNAME": "Dexpanthenol 6.6 mg/mL / Pyridoxine HCl 2.7 mg/mL / Thiamine HCl 2.6 mg/mL / Niacinamide 2.6 mg/mL / Riboflavin 0.05 mg/mL/ Magnesium Chloride Hexahydrate 10.5 mg/mL / Calcium Gluconate1.3 mg/mL / Cyanocobalamin 0.03 mg/mL 50mL",
    "PACKAGEDESCRIPTION": "50 mL in 1 VIAL (72682-6858-1) ",
    "ACTIVEINGREDIENTSINFO": "2.7 mg/1 mL; 10.5 mg/1 mL; 6.6 mg/1 mL; 1.3 mg/1 mL; 75 mg/1 mL; 2.6 mg/1 mL; .03 mg/1 mL; .05 mg/1 mL",
    "MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
    "PROPRIETARYNAMESUFFIX": ""
}

Normalization notes#

[]

Current status projection#

Dataset: compounder
Record Source: ndc_compounder_zip
Source Record Id: compounder:580
Source Row Number: 580
Status Scope: package
Lookup Ndc: 72682-6858-1
Lookup Ndc Digits: 7268268581
Product Ndc: 72682-6858
Product Ndc Digits: 726826858
Package Ndc: 72682-6858-1
Package Ndc Digits: 7268268581
Package Ndc11: 72682685801
Product Id: [empty]
Status Code: COMPOUNDER
Status Label: Outsourcing facility compounded drug report
Reporting Period Raw: 2025-1
Reporting Period: 2025-1
Source Table: fda_ndc_aux_compounder
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Row Hash: 008361e3f34317c374d8cebfaa4b413ed17010d16730a2590d3f8282dfbdc45e
Import Run Id: 20261021T042902Z
Loaded At: 2026-10-21 04:33:26